“Every person should have a toolkit of the things that bring them out of the psychological and physical distress that dysregulates their nervous...
Efbemalenograstim has been approved by the FDA to combat infections in adults being treated for nonmyeloid cancers.
The agency is evaluating the need for regulatory action on the links between CAR T-cell immunotherapies and secondary blood cancers.
Researchers compared the reduction in drug waste and cost savings from redispensing oral anticancer drugs versus the standard practice of...
The case raises ethical and legal questions about whether AI can replace or supplement human tasks and interactions.
Some employers play on the fact that younger doctors ... tend to be trusting or feel they don’t have negotiation power.
FDA’s ODAC committee pressed for resolution on whether 2 lymphoma drugs, long on the U.S. market, actually deliver significant benefits to...
From the Journals
Policy interventions and advocacy efforts at the patient, clinician, and hospital level will be needed to reform the PA process.
Mortality rates from early-stage ocular MALT lymphoma are low, with relapse rates lowered by radiation therapy.
Vast medical databases have connected dots where smaller randomized trials could not. But the United States has a long way to go.
Building a sustainable oncology workforce will not be easy, but improving staffing shortages and integrating resilience training can help, experts...